• Explore /
  • Poster
  • / Prognostic impact of dose, duration, and timing of corticosteroid therapy in patients with large B-cell lymphoma treated with standard of care axicabtagene ciloleucel (Axi-cel).

Prognostic impact of dose, duration, and timing of corticosteroid therapy in patients with large B-cell lymphoma treated with standard of care axicabtagene ciloleucel (Axi-cel).

Abstract Poster

Authors

null

Paolo Strati

The University of Texas MD Anderson Cancer Center, Department of Lymphoma/Myeloma, Houston, TX

Paolo Strati , fateeha furqan , Jason Westin , Luis Fayad , Sairah Ahmed , Hun Ju Lee , Swaminathan Padmanabhan Iyer , Ranjit Nair , Loretta J. Nastoupil , Simrit Parmar , Maria Alma Rodriguez , Felipe Samaniego , Raphael Steiner , Michael Wang , Chelsea Camille Pinnix , Christopher Flowers , Sandra B. Horowitz , Catherine Classen , Haleigh Mistry , Sattva Swarup Neelapu

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 ASCO Virtual Scientific Program

Session Type

Poster Discussion Session

Session Title

Hematologic Malignancies—Lymphoma and Chronic Lymphocytic Leukemia

Track

Hematologic Malignancies

Sub Track

Non-Hodgkin Lymphoma

Citation

J Clin Oncol 38: 2020 (suppl; abstr 8011)

DOI

10.1200/JCO.2020.38.15_suppl.8011

Abstract #

8011

Poster Bd #

344

Abstract Disclosures

Similar Posters

First Author: Sairah Ahmed

First Author: Brodie Miles

First Author: Jason Westin

First Author: Donald Patrick